111 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
6 Jun 24
Submission of Matters to a Vote of Security Holders
4:29pm
, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust … is required.
21. Clawback. The Administrator may specify in an Award Agreement that the Participant’s rights, payments, and/or benefits with respect
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
occurred or is reasonably expected to occur, (C) the fair market value of the assets under each Plan exceeds the present value of all benefits accrued under … to reflect the relative benefits received by the Company and by the Underwriters from the Offering or, if such allocation is not permitted by applicable law
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
-U.S. Holder’s entitlement to benefits under that treaty. Such form must be provided prior to the payment of dividends and must be updated periodically
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
appropriate form, certifying the Non-U.S. Holder’s entitlement to benefits under that treaty. Such form must be provided prior to the payment of dividends
8-K
EX-10.1
gp3aagphsu vz
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-3ASR
EX-5.1
ichyqx2
2 Jan 24
Automatic shelf registration
4:06pm
S-3ASR
EX-4.3
7z1bpk0r
2 Jan 24
Automatic shelf registration
4:06pm
8-K
EX-10.1
9kve5
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
pqtxx3ylf7 wwq8
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
vktw14c3qh 4i6tak6
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
0biufmk towe5
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
pg5g4rkswrc2xep4myt
27 Sep 23
Prospectus supplement for primary offering
5:26pm